Research Digest

Lab notes: Asthma drug can help treat TB and counter antibiotic resistance

The drug targets metabolic pathways essential for survival of the TB pathogen.

In their search for new drugs against tuberculosis which is increasingly becoming resistant to presently available drugs, researchers are exploring all options. Scientists at the Indian Institute of Science in Bangalore have found that an existing anti-asthma drug is effective against tuberculosis and can help address the problem of drug resistance as well.

The researchers, through extensive studies, have found that the drug Pranlukast destroys a specific metabolic pathway in Mycobacterium tuberculosis, the causative agent of TB, which is crucial for its survival in human cells. And it does so without causing any damage to host cells. The pathway was till now not known as a drug target for TB.

Traditionally, drugs are used to prevent ability of bacteria to replicate in their host – human body – but this has adverse effects on host cells. In order to overcome this problem, researchers looked for an agent that targets metabolic pathways essential for survival of the TB pathogen. They found that the pathogen used a mechanism called arginine biosynthesis is essential for its survival, and if it is inhibited the pathogen would die. Pranlukast fitted this role.

“Our approach involves targeting tuberculosis in a two-fold manner. We have discovered that Pranlukast acts as a potent inhibitor against M tuberculosis, and have demonstrated that it works by directly targeting the pathogen as well as subverting its strategies to conquer within the host,” said Archita Mishra, who did the work as part of her PhD under Professor Avadhesha Surolia.

The drug targets a unique arginine biosynthesis enzyme which is exclusive to Mtb, thereby impeding its arginine production. It also targets the pathogen pro-survival pathways in the host, directly reducing intracellular survival of the TB bacteria.

Since Pranlukast is an FDA approved molecule and is already being used as an anti-asthmatic drug in various parts of the world, it has the potential to be included directly into the therapeutic regime against TB. “Our work proposes a combination of Pranlukast with the standard-of-care therapy drugs, to be highly efficient against TB pathogen, thereby providing an opportunity to use this novel drug combinations for TB therapeutics,” explained Surolia. The results of the study have been published in journal EMBO Molecular Medicine.

The work also demonstrates how new drug discovery cycle can be shortened. “In contrast to conventional drug discovery methods, we employed the ‘drug repurposing’ approach wherein FDA-approved drug datasets are used for screening. This significantly shortens the screening timeline and also suggests human safety of such drugs molecules,” explained Mishra.

The combinations tested have shown that smaller concentrations of standard TB drugs would be needed when used along with Pranlukast. The results have also not shown any side effects in animal studies. The drug is already in market as an anti-asthmatic drug and is safe for human consumption.

“We are further exploring the detailed mechanism of action of Pranlukast to get deeper insights in pre-clinical models. Since it is an FDA approved drug we are also planning to engage with clinical collaborators for trials in future,” Surolia added.

The study is supported by grant from Department of Science and Technology and partially from the Council of Scientific and Industrial Research, Indian Council of Medical Research , and Department of Biotechnology.

The research team included Archita Mishra, Ashalatha S Mamidi, Raju S Rajmani, Ananya Ray, Rajanya Roy and Avadhesha Surolia.

This article was first published by India Science Wire.

We welcome your comments at
Sponsored Content BY 

When did we start parenting our parents?

As our parents grow older, our ‘adulting’ skills are tested like never before.

From answering every homework question to killing every monster under the bed, from soothing every wound with care to crushing anxiety by just the sound of their voice - parents understandably seemed like invincible, know-it-all superheroes all our childhood. It’s no wonder then that reality hits all of a sudden, the first time a parent falls and suffers a slip disc, or wears a thick pair of spectacles to read a restaurant menu - our parents are growing old, and older. It’s a slow process as our parents turn from superheroes to...human.

And just as slow to evolve are the dynamics of our relationship with them. Once upon a time, a peck on the cheek was a frequent ritual. As were handmade birthday cards every year from the artistically inclined, or declaring parents as ‘My Hero’ in school essays. Every parent-child duo could boast of an affectionate ritual - movie nights, cooking Sundays, reading favourite books together etc. The changed dynamic is indeed the most visible in the way we express our affection.

The affection is now expressed in more mature, more subtle ways - ways that mimics that of our own parents’ a lot. When did we start parenting our parents? Was it the first time we offered to foot the electricity bill, or drove them to the doctor, or dragged them along on a much-needed morning walk? Little did we know those innocent acts were but a start of a gradual role reversal.

In adulthood, children’s affection for their parents takes on a sense of responsibility. It includes everything from teaching them how to use smartphones effectively and contributing to family finances to tracking doctor’s appointments and ensuring medicine compliance. Worry and concern, though evidence of love, tend to largely replace old-fashioned patterns of affection between parents and children as the latter grow up.

It’s something that can be easily rectified, though. Start at the simplest - the old-fashioned peck on the cheek. When was the last time you gave your mom or dad a peck on the cheek like a spontaneous five-year-old - for no reason at all? Young parents can take their own children’s behaviour available as inspiration.

As young parents come to understand the responsibilities associated with caring for their parents, they also come to realise that they wouldn’t want their children to go through the same challenges. Creating a safe and secure environment for your family can help you strike a balance between the loving child in you and the caring, responsible adult that you are. A good life insurance plan can help families deal with unforeseen health crises by providing protection against financial loss. Having assurance of a measure of financial security for family can help ease financial tensions considerably, leaving you to focus on being a caring, affectionate child. Moreover,you can eliminate some of the worry for your children when they grow up – as the video below shows.


To learn more about life insurance plans available for your family, see here.

This article was produced by the Scroll marketing team on behalf of SBI Life and not by the Scroll editorial team.